According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, and Laboratory Corporation of America Holdings Orexigen Therapeutics, Inc. (OREX, Financial): President and CEO Michael Narachi sold 150,000 Shares
President and CEO of Orexigen Therapeutics, Inc. (OREX) Michael Narachi sold 150,000 shares on 07/13/2012 at an average price of $6.7. OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. Orexigen Therapeutics, Inc. has a market cap of $392.4 million; its shares were traded at around $7.06 with and P/S ratio of 114.5.
Orexigen Therapeutics Inc reported net loss of $10.4 million and revenues of $857,000 for their 2012 first quarter results.
President and CEO Michael Narachi sold 375,000 shares of OREX stock in June and July. Chief Business Officer Joseph P Hagan sold 241,309 shares of OREX stock in June and July.
Gas Natural Inc (EGAS, Financial): Chairman and CEO, 10% Owner Richard M Osborne sold 100,000 Shares
Chairman and CEO, 10% Owner of Gas Natural Inc (EGAS) Richard M Osborne sold 100,000 shares on 07/12/2012 at an average price of $10.1. Gas Natural Inc., formerly known as Energy, Inc., distributes and sells natural gas to end-use residential, commercial, and industrial customers. Gas Natural Inc has a market cap of $83.1 million; its shares were traded at around $10.2 with a P/E ratio of 24.9 and P/S ratio of 0.8. The dividend yield of Gas Natural Inc stocks is 5.3%. Gas Natural Inc had an annual average earnings growth of 17.1% over the past 10 years.
Gas Natural Inc announced their 2012 first quarter financial results on May 15, 2012. The Company reported net income of $3.3 million and total revenues of $33.8 million.
Chairman and CEO, 10% Owner Richard M Osborne sold 800,000 shares of EGAS stock in July.
The Middleby Corporation (MIDD, Financial): CEO, Chairman, President Selim A Bassoul sold 100,000 Shares
CEO, Chairman, President of The Middleby Corporation (MIDD) Selim A Bassoul sold 100,000 shares on 07/06/2012 at an average price of $100. MIDDLEBY CORP. through its subsidiaries and their operating divisions, is engaged in the manufacture and sale of commercial foodservice equipment and beverage merchandisers. The Middleby Corporation has a market cap of $1.86 billion; its shares were traded at around $99.67 with a P/E ratio of 18.4 and P/S ratio of 2.2. The Middleby Corporation had an annual average earnings growth of 25.6% over the past 10 years. GuruFocus rated The Middleby Corporation the business predictability rank of 2.5-star.
The Middleby Corp. reported their 2012 first quarter financial results. The Company reported net earnings of $22.1 million, or $1.20 per share. Net sales for this quarter were $228.8 million.
CEO, Chairman, President Selim A Bassoul sold 154,286 shares of MIDD stock in March, April and July. CFO Timothy John Fitzgerald sold 17,432 shares of MIDD stock from February to May. Director Sabin C Streeter and Director Ryan Levenson sold 3,600 shares of MIDD stock in March and May.
Laboratory Corp. of America Holdings (LH, Financial): President & CEO David P King sold 84,800 Shares
President & CEO of Laboratory Corp. of America Holdings (LH) David P King sold 84,800 shares on 07/09/2012 at an average price of $92.11. Laboratory Corporation of America Holdings, is one of the largest independent clinical laboratory company's in the United States. Laboratory Corp. Of America Holdings has a market cap of $8.9 billion; its shares were traded at around $95.23 with a P/E ratio of 14 and P/S ratio of 1.6. Laboratory Corp. Of America Holdings had an annual average earnings growth of 14.8% over the past 10 years. GuruFocus rated Laboratory Corp. Of America Holdings the business predictability rank of 5-star.
Laboratory Corporation announced their 2012 first quarter financial results. The Company reported net earnings for this quarter was $161.6 million and revenues were $1.4 billion.
President & CEO David P King sold 104,800 shares of LH stock in January and July. CFO, EVP William B Hayes sold 93,061 shares of LH stock in March. Chief Information Officer Lidia Fonseca, Chief Legal Officer, Secretary F Samuel Eberts III, Director Wendy E Lane, and Director Jean-luc Belingard sold 7,028 shares of LH stock in May and June.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.
President and CEO of Orexigen Therapeutics, Inc. (OREX) Michael Narachi sold 150,000 shares on 07/13/2012 at an average price of $6.7. OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. Orexigen Therapeutics, Inc. has a market cap of $392.4 million; its shares were traded at around $7.06 with and P/S ratio of 114.5.
Orexigen Therapeutics Inc reported net loss of $10.4 million and revenues of $857,000 for their 2012 first quarter results.
President and CEO Michael Narachi sold 375,000 shares of OREX stock in June and July. Chief Business Officer Joseph P Hagan sold 241,309 shares of OREX stock in June and July.
Gas Natural Inc (EGAS, Financial): Chairman and CEO, 10% Owner Richard M Osborne sold 100,000 Shares
Chairman and CEO, 10% Owner of Gas Natural Inc (EGAS) Richard M Osborne sold 100,000 shares on 07/12/2012 at an average price of $10.1. Gas Natural Inc., formerly known as Energy, Inc., distributes and sells natural gas to end-use residential, commercial, and industrial customers. Gas Natural Inc has a market cap of $83.1 million; its shares were traded at around $10.2 with a P/E ratio of 24.9 and P/S ratio of 0.8. The dividend yield of Gas Natural Inc stocks is 5.3%. Gas Natural Inc had an annual average earnings growth of 17.1% over the past 10 years.
Gas Natural Inc announced their 2012 first quarter financial results on May 15, 2012. The Company reported net income of $3.3 million and total revenues of $33.8 million.
Chairman and CEO, 10% Owner Richard M Osborne sold 800,000 shares of EGAS stock in July.
The Middleby Corporation (MIDD, Financial): CEO, Chairman, President Selim A Bassoul sold 100,000 Shares
CEO, Chairman, President of The Middleby Corporation (MIDD) Selim A Bassoul sold 100,000 shares on 07/06/2012 at an average price of $100. MIDDLEBY CORP. through its subsidiaries and their operating divisions, is engaged in the manufacture and sale of commercial foodservice equipment and beverage merchandisers. The Middleby Corporation has a market cap of $1.86 billion; its shares were traded at around $99.67 with a P/E ratio of 18.4 and P/S ratio of 2.2. The Middleby Corporation had an annual average earnings growth of 25.6% over the past 10 years. GuruFocus rated The Middleby Corporation the business predictability rank of 2.5-star.
The Middleby Corp. reported their 2012 first quarter financial results. The Company reported net earnings of $22.1 million, or $1.20 per share. Net sales for this quarter were $228.8 million.
CEO, Chairman, President Selim A Bassoul sold 154,286 shares of MIDD stock in March, April and July. CFO Timothy John Fitzgerald sold 17,432 shares of MIDD stock from February to May. Director Sabin C Streeter and Director Ryan Levenson sold 3,600 shares of MIDD stock in March and May.
Laboratory Corp. of America Holdings (LH, Financial): President & CEO David P King sold 84,800 Shares
President & CEO of Laboratory Corp. of America Holdings (LH) David P King sold 84,800 shares on 07/09/2012 at an average price of $92.11. Laboratory Corporation of America Holdings, is one of the largest independent clinical laboratory company's in the United States. Laboratory Corp. Of America Holdings has a market cap of $8.9 billion; its shares were traded at around $95.23 with a P/E ratio of 14 and P/S ratio of 1.6. Laboratory Corp. Of America Holdings had an annual average earnings growth of 14.8% over the past 10 years. GuruFocus rated Laboratory Corp. Of America Holdings the business predictability rank of 5-star.
Laboratory Corporation announced their 2012 first quarter financial results. The Company reported net earnings for this quarter was $161.6 million and revenues were $1.4 billion.
President & CEO David P King sold 104,800 shares of LH stock in January and July. CFO, EVP William B Hayes sold 93,061 shares of LH stock in March. Chief Information Officer Lidia Fonseca, Chief Legal Officer, Secretary F Samuel Eberts III, Director Wendy E Lane, and Director Jean-luc Belingard sold 7,028 shares of LH stock in May and June.
For the complete list of stocks that bought by their CEOs, go to: Insider Buys.
